L-364373

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameL-364373

Drug Alias Namebenzodiazepines (Merck)[(3-R)-1, 3-dihydro-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-methyl-2H- 1,4-benzodiazepin-2-oneL-3L-364373R-L-3

ClassificationSmall molecules

Mechanisms of ActionPotassium channel agonists

TargetsPotassium channel

Therapy Area/IndicationsHypertensionArrhythmias, Cardiac

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck Research Laboratories

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Research Laboratories

Active IndicationsN/A

Inactive IndicationsHypertensionArrhythmias, Cardiac

Other Information

ATC CodeN/A